Email
Password
Remember meForgot password?
    Log in with Twitter

Pfizer News

Pfizer first dose 85% effective after 2-4 weeks: study

Jerusalem - The first dose of the Pfizer vaccination is 85 percent effective against coronavirus infection between two and four weeks after inoculation, according to a study published in the Lancet medical journal.

Looking behind the North Korea cyberattack on Pfizer Special

For a country that allegedly has no cases of COVID-19, it is interesting to see the apparent attack by the state upon the drug company Pfizer with the aim to acquire coronavirus vaccine technology.

One million vaccinated as US eyes return to normal next summer

Washington - More than a million Americans have received the first dose of their Covid-19 vaccines, a senior official said Wednesday, as the US eyes a return to normal by next summer.

US health worker has serious allergic reaction to Pfizer vaccine

Washington - A health worker in Alaska suffered a serious allergic reaction after getting Pfizer-BioNTech's Covid-19 vaccine and is now hospitalized but stable, a report said Wednesday.

US approves Pfizer-BioNTech Covid vaccine: statement

Washington - The US green lighted the Pfizer-BioNTech Covid-19 vaccine late Friday, paving the way for its imminent rollout across the country, with President Donald Trump promising the first immunizations would take place "in less than 24 hours.

White House reportedly tells US regulator to approve vaccine or quit

Washington - US President Donald Trump's White House reportedly told the head of the country's drug regulator to approve Pfizer-BioNTech's Covid vaccine by the end of Friday or resign, after indications the first immunizations were imminent.

Pfizer CEO — Not sure if vaccine will stop transmission of virus

Pfizer Inc’s CEO Albert Bourla has said that the company is “not certain” if its COVID-19 vaccine candidate developed in collaboration with German drugmaker BioNTech SE prevented the transmission of the novel coronavirus.

EU regulator to decide on Pfizer/BioNTech Covid-19 jab first

Frankfurt Am Main - Europe's medicines regulator said Tuesday it would decide by December 29 whether to grant emergency approval to a Covid-19 vaccine developed by Germany's BioNTech and its US partner Pfizer, ahead of a rival treatment from Moderna.

Pfizer/BioNTech file for emergency approval for virus vaccine

Washington - Pfizer confirmed Friday that it and partner BioNTech have applied for emergency use authorization for their coronavirus vaccine, becoming the first to do so in the US or Europe as the pandemic rages around the world.

Pfizer: the firm making major progress toward Covid vaccine

New York - Pfizer, in partnership with German company BioNTech, announced this week major progress in its quest to release a vaccine against Covid-19. Here are some key questions and answers about the US firm and its long history:- How did the company begin?

Pfizer CEO sold $5.6 million in stock on day of vaccine announcement

Washington - Pfizer CEO Albert Bourla sold $5.6 million of his stock in the US pharmaceutical company on the same day it announced promising results for its Covid-19 vaccine candidate, filings showed Wednesday.

Biden: Vaccine news gives 'hope,' but long battle ahead

Wilmington - US President-elect Joe Biden Monday hailed as a cause for "hope" the news that a Covid-19 vaccine developed by Pfizer and BioNTech was 90 percent effective -- but warned of a long battle still ahead.

'Watershed' Covid-19 vaccine proves 90 percent effective

Paris - A vaccine jointly developed by Pfizer and BioNTech was 90 percent effective in preventing Covid-19 infections in ongoing Phase 3 trials, the companies announced Monday.

Exxon Mobil dropped from the Dow Jones after Apple stock split

New York - Exxon Mobil, which joined the Dow Jones Industrial Average in 1928, is being removed from the blue-chip stock market index. Its replacement: enterprise software company Salesforce.com.

Pfizer helps Indian government with antimicrobial resistance

New Delhi - The major drugs company Pfizer is working closely with the Indian Council of Medical Research (ICMR) to help combat antimicrobial resistance in India. This includes establishing a center in New Delhi to develop research.

Suicide risk lifted from Pfizer's smoking-cessation pill

Brussels - Europe's drug regulator has lifted a longstanding warning in relation to a anti-smoking medication made by the company Pfizer.

Pfizer's pneumococcal vaccine challenged by MSF

The issue of patents, the cost of medicine, and the practices of pharmaceutical companies has come to ahead through a challenge about the manufacture and distribution of a pneumococcal vaccine.

The world’s biggest pharma company created

Two big deals in the world of pharmaceuticals have been announced this week. Pfizer has announced it is to merge with Allergan; and Shire is making a bid for Baxalta.

Pfizer to buy Allergan for $160 billion

Pfizer is planning to buy Allergan for $160 billion. When the deal is completed, it will become the world's largest drug company.

Op-Ed: Pfizer to buy Allergan in $160 billion deal

Foreclosures and short sales dropped to 6 percent in October, down from 9 percent a year ago, and the lowest level since the National Association of Realtors stared tracking distressed sales in October 2008.

Op-Ed: The S&P 500 index gained 3.3% for the week

Since 1987, DJIA has logged gains in 22 of 28 years from the close on Friday after Thanksgiving to year-end. The S&P 500 is up 0.5 percent in November and 1.5 percent thus far in 2015. There are 28 trading days remaining in 2015.

CMA accuses Pfizer and Flynn Pharma of overcharging

The UK's watchdog is accusing pharmaceutical firms Pfizer and Flynn Pharma of charging unfair prices for an anti-epilepsy drug.

Pfizer once-daily arthritis tablets reach FDA review

Pharmaceutical company Pfizer has announced that it is getting closer to producing a once-per-day table designed to reduce the effects of arthritis. The tablets are currently being reviewed by the U.S. FDA.

Pfizer buys leading drugs from GSK to extend market share

Pharmaceutical company Pfizer has purchased two vaccine manufacturers from GSK: Nimenrix and Mencevax. These products extend the company’s interest in this field.

Pfizer to acquire Hospira in big pharma sale

The pharmaceutical Pfizer giant is purchasing the injectable drugmaker Hospira for a reported $15 billion. This represents a new area for Pfizer.

Pfizer recalls antidepressants after pharmacist finds heart drug

A pharmacist found that a bottle of antidepressant Effexor XR contained one capsule of Tikosyn 0.25 milligram (dofetilide), which is used to treat heart rhythm disorders.

Pfizer to appeal loss of Celebrex patent

New York - Pharmaceutical giant Pfizer said on Wednesday it will appeal a US federal court's refusal to extend patent protection for its blockbuster Celebrex drug used to treat arthritis.Pfizer said the US District Court for the Eastern District of Virginia inval...

Pfizer profits fall, but beat expectations

New York - US pharmaceutical giant Pfizer Tuesday reported a big drop in quarterly profits, but bested analyst expectations and pointed to several new drugs in development.

Pfizer to start selling Viagra online

Men who do not like to go to the drugstore to buy Viagra will now have another option. They will be able to go online and buy Viagra directly from Pfizer.

Drug company's problem causes TB drug shortage

The pharma company Pfizer has announces that vials of Rifampin, used to treat tuberculosis, are in short supply due to manufacturing and possible contamination issues.
  1 2 Next»

Set up a news alert for

Pfizer


Pfizer Image

Pfizer world headquaters  New York
Pfizer world headquaters, New York
Jim.henderson (CC0 1.0)

Latest News
Top News